On Thursday, April 16 at 10:05PM, Biological Dynamics President and CTO, David Charlot, PhD, is presenting "Quantification of Circulating Biomarkers from Plasma and Serum Using AC Electrokinetics".
In addition, VP of Clinical R&D, Juan Pablo Hinestrosa, PhD hosts a poster presentation, titled "Longitudinal Tracking of Necrotic Cell-Free DNA in Patients with Ontological Disease."
Interest in the isolation, quantification, and analysis of cell-free biomarkers directly from blood has grown significantly. Biological Dynamics has developed proprietary platforms for isolating and quantifying large circulating biomarkers from physiological solutions using AC Electrokinetics (ACE). Biomarkers, such as necrotic cell-free DNA (ncfDNA), have been established as indicators of cancer, and the ability to detect and track these biomarkers unlocks a new era in early disease diagnosis and treatment response monitoring.